Suboptimal Adherence to Combination Antiretroviral Therapy Is Associated With Higher Levels of Inflammation Despite HIV Suppression (Q39359637)

9 January 2018

title

Suboptimal Adherence to Combination Antiretroviral Therapy Is Associated With Higher Levels of Inflammation Despite HIV Suppression (English)

1 reference

9 January 2018

main subject

anti-retroviral agent

0 references

0 references

4

Frank J Palella

1 reference

9 January 2018

Kristine Erlandson

3

object named as

Kristine M Erlandson

1 reference

9 January 2018

author name string

Jose R Castillo-Mancilla

1

1 reference

9 January 2018

Todd T Brown

2

1 reference

9 January 2018

Edward M Gardner

5

1 reference

9 January 2018

Bernard J C Macatangay

6

1 reference

9 January 2018

Elizabeth C Breen

7

1 reference

9 January 2018

Lisa P Jacobson

8

1 reference

9 January 2018

Peter L Anderson

9

1 reference

9 January 2018

Nikolas I Wada

10

1 reference

9 January 2018

language of work or name

English

0 references

publication date

22 September 2016

1 reference

9 January 2018

Clinical Infectious Diseases

published in

1 reference

9 January 2018

volume

63

1 reference

9 January 2018

issue

12

1 reference

9 January 2018

page(s)

1661-1667

1 reference

9 January 2018

Rosuvastatin Is Effective to Decrease CD8 T-Cell Activation Only in HIV-Infected Patients With High Residual T-Cell Activation Under Antiretroviral Therapy

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5146724

Adherence and HIV RNA Suppression in the Current Era of Highly Active Antiretroviral Therapy

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5146724

Antiretroviral regimen and suboptimal medication adherence are associated with low-level human immunodeficiency virus viremia

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5146724

The effect of HAART-induced HIV suppression on circulating markers of inflammation and immune activation

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5146724

Differential Reduction in Monocyte Activation and Vascular Inflammation With Integrase Inhibitor-Based Initial Antiretroviral Therapy Among HIV-Infected Individuals

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5146724

Association of residual plasma viremia and intima-media thickness in antiretroviral-treated patients with controlled human immunodeficiency virus infection

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5146724

Elevated levels of monocyte activation markers are associated with subclinical atherosclerosis in men with and those without HIV infection

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5146724

Level of adherence and HIV RNA suppression in the current era of highly active antiretroviral therapy (HAART)

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5146724

Sevelamer does not decrease lipopolysaccharide or soluble CD14 levels but decreases soluble tissue factor, low-density lipoprotein (LDL) cholesterol, and oxidized LDL cholesterol levels in individuals with untreated HIV infection

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5146724

Soluble markers of inflammation and coagulation but not T-cell activation predict non-AIDS-defining morbid events during suppressive antiretroviral treatment

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5146724

The Significance of Interferon-γ in HIV-1 Pathogenesis, Therapy, and Prophylaxis

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5146724

Incomplete adherence to antiretroviral therapy is associated with higher levels of residual HIV-1 viremia

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5146724

Serious Non-AIDS events: Immunopathogenesis and interventional strategies

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5146724

Factors contributing to risk for cancer among HIV-infected individuals, and evidence that earlier combination antiretroviral therapy will alter this risk

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5146724

Prospective antiretroviral treatment of asymptomatic, HIV-1 infected controllers

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5146724

Residual immune dysregulation syndrome in treated HIV infection

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5146724

Metabolic and cardiovascular complications in HIV-infected patients: new challenges for a new age

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5146724

Levels of adherence required for virologic suppression among newer antiretroviral medications

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5146724

Risk of viral failure declines with duration of suppression on highly active antiretroviral therapy irrespective of adherence level

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5146724

Inflammatory biomarkers and abacavir use in the Women's Interagency HIV Study and the Multicenter AIDS Cohort Study

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5146724

Inflammation and mortality in HIV-infected adults: analysis of the FRAM study cohort

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5146724

The risk of virologic failure decreases with duration of HIV suppression, at greater than 50% adherence to antiretroviral therapy

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5146724

Antiretroviral medication adherence and the development of class-specific antiretroviral resistance

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5146724

Decreased adherence to antiretroviral therapy observed prior to transient human immunodeficiency virus type 1 viremia

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5146724

Adherence-resistance relationships to combination HIV antiretroviral therapy

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5146724

Continued improvement in survival among HIV-infected individuals with newer forms of highly active antiretroviral therapy

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5146724

CD4+ count-guided interruption of antiretroviral treatment

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5146724

Durability of adherence to antiretroviral therapy on initial and subsequent regimens

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5146724

Assessing antiretroviral adherence via electronic drug monitoring and self-report: an examination of key methodological issues

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5146724

Adherence to antiretroviral therapy by human immunodeficiency virus-infected patients

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5146724

The Multicenter AIDS Cohort Study: rationale, organization, and selected characteristics of the participants.

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5146724

Detectable HIV viral load is associated with metabolic syndrome

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5146724

Parametric survival analysis and taxonomy of hazard functions for the generalized gamma distribution

21 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5146724

Interrelationships among circulating interleukin-6, C-reactive protein, and traditional cardiovascular risk factors in women

21 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5146724

Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing

21 August 2018

1 reference

Crossref

https://api.crossref.org/works/10.1093%2FCID%2FCIW650

Low-level HIV viremia is associated with microbial translocation and inflammation

21 January 2018

1 reference

12 December 2020

Episodes of HIV viremia and the risk of non-AIDS diseases in patients on suppressive antiretroviral therapy

1 reference

12 December 2020

Modest nonadherence to antiretroviral therapy promotes residual HIV-1 replication in the absence of virological rebound in plasma

1 reference

12 December 2020

Inflammation in Chronic HIV Infection: What Can We Do?

1 reference

12 December 2020

Identifiers

DOI

10.1093/CID/CIW650

1 reference

9 January 2018

PMC publication ID

5146724

1 reference

9 January 2018

PubMed publication ID

27660234

1 reference

9 January 2018